Literature DB >> 31528108

It is time for an ethical, evidence-based approach to youth presenting to the ED with an opioid overdose.

Tom Warshawski1, Curren Warf2.   

Abstract

Currently, there is a dangerous inconsistency between our current understanding of adolescent development and the effects of drugs on cognition when compared to our collective approach to youth who present in the emergency department with an opioid overdose. We call upon practitioners to embrace a new paradigm and we ask the Canadian Pediatric Society (CPS) to spearhead the development of guidelines to advise on best practices to manage youth who present to the emergency department with an illicit drug overdose.

Entities:  

Keywords:  Adolescent; Fentanyl; Opioid; Overdose

Year:  2019        PMID: 31528108      PMCID: PMC6735634          DOI: 10.1093/pch/pxz011

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  2 in total

1.  Time to act: Early experience suggests stabilization care offers a feasible approach for adolescents after acute life-threatening opioid toxicity.

Authors:  Eva M Moore; Tom Warshawski; Sara Jassemi; Grant Charles; Dzung X Vo
Journal:  Paediatr Child Health       Date:  2022-06-01       Impact factor: 2.600

2.  Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among Youth.

Authors:  Michael Krausz; Jean N Westenberg; Vivian Tsang; Janet Suen; Martha J Ignaszewski; Nickie Mathew; Pouya Azar; Maurice Cabanis; Julie Elsner; Marc Vogel; Renske Spijkerman; Laura Orsolini; Dzung Vo; Eva Moore; Jessica Moe; Johannes Strasser; Patrick Köck; Calin Marian; Kenneth M Dürsteler; Markus Backmund; Jeanette Röhrig; Marianne Post; Hans Haltmayer; Wolfgang Wladika; Thomas Trabi; Christian Muller; Gerhard Rechberger; Maree Teesson; Michael Farrell; Grant Christie; Sally Merry; Mostafa Mamdouh; Rachel Alinsky; Sharon Levy; Marc Fishman; Richard Rosenthal; Kerry Jang; Fiona Choi
Journal:  Medicina (Kaunas)       Date:  2022-04-13       Impact factor: 2.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.